Ocean Biomedical Performance

OCEAWDelisted Stock   0.0009  0.00  0.00%   
The company holds a Beta of 16.12, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ocean Biomedical will likely underperform. Ocean Biomedical right now holds a risk of 0.0%. Please check Ocean Biomedical total risk alpha, as well as the relationship between the potential upside and kurtosis , to decide if Ocean Biomedical will be following its historical price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Ocean Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ocean Biomedical is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
  

Ocean Biomedical Relative Risk vs. Return Landscape

If you would invest  0.09  in Ocean Biomedical on October 31, 2025 and sell it today you would earn a total of  0.00  from holding Ocean Biomedical or generate 0.0% return on investment over 90 days. Ocean Biomedical is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Ocean, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Ocean Biomedical Target Price Odds to finish over Current Price

The tendency of Ocean Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0009 90 days 0.0009 
about 91.25
Based on a normal probability distribution, the odds of Ocean Biomedical to move above the current price in 90 days from now is about 91.25 (This Ocean Biomedical probability density function shows the probability of Ocean Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 16.12 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ocean Biomedical will likely underperform. In addition to that Ocean Biomedical has an alpha of 13.3176, implying that it can generate a 13.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Ocean Biomedical Price Density   
       Price  

Predictive Modules for Ocean Biomedical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ocean Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00090.00
Details
Naive
Forecast
LowNextHigh
000
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.001700.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ocean Biomedical. Your research has to be compared to or analyzed against Ocean Biomedical's peers to derive any actionable benefits. When done correctly, Ocean Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ocean Biomedical.

Ocean Biomedical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ocean Biomedical is not an exception. The market had few large corrections towards the Ocean Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ocean Biomedical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ocean Biomedical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
13.32
β
Beta against Dow Jones16.12
σ
Overall volatility
0.01
Ir
Information ratio 0.15

Ocean Biomedical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ocean Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ocean Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ocean Biomedical is not yet fully synchronised with the market data
Ocean Biomedical has some characteristics of a very speculative penny stock
Ocean Biomedical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0.
Ocean Biomedical generates negative cash flow from operations
Latest headline from news.google.com: Renovation Expert Dave Colver of Easton, PA Shares a Kitchen Remodeling Checklist in HelloNation - PR Newswire

Ocean Biomedical Fundamentals Growth

Ocean Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ocean Biomedical, and Ocean Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ocean Pink Sheet performance.

About Ocean Biomedical Performance

Evaluating Ocean Biomedical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ocean Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ocean Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.

Things to note about Ocean Biomedical performance evaluation

Checking the ongoing alerts about Ocean Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ocean Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ocean Biomedical is not yet fully synchronised with the market data
Ocean Biomedical has some characteristics of a very speculative penny stock
Ocean Biomedical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0.
Ocean Biomedical generates negative cash flow from operations
Latest headline from news.google.com: Renovation Expert Dave Colver of Easton, PA Shares a Kitchen Remodeling Checklist in HelloNation - PR Newswire
Evaluating Ocean Biomedical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ocean Biomedical's pink sheet performance include:
  • Analyzing Ocean Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ocean Biomedical's stock is overvalued or undervalued compared to its peers.
  • Examining Ocean Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ocean Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ocean Biomedical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ocean Biomedical's pink sheet. These opinions can provide insight into Ocean Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ocean Biomedical's pink sheet performance is not an exact science, and many factors can impact Ocean Biomedical's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Ocean Pink Sheet

If you are still planning to invest in Ocean Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocean Biomedical's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories